HKSH Announces Pioneering Research Findings on Immunotherapy for Co-morbid Allergic Conditions

(31 December 2019, Hong Kong) A two-year pioneering research study on the effectiveness of Allergen Immunotherapy (AIT) on co-morbid diseases was conducted by Allergy Centre of Hong Kong Sanatorium & Hospital (HKSH) with findings published in the international medical journal Immunotherapy in November 2019. A total of 120 patients with house dust mite-induced allergic rhinitis joined the treatment programme under this Study. Results showed that AIT could remarkably reduce the symptoms of allergic rhinitis by over 50% while also effectively relieving other co-morbid allergic conditions including asthma, conjunctivitis and atopic dermatitis (or eczema). As the first clinical study on AIT in Hong Kong, the Study is also an international first that focuses on the effectiveness of AIT for co-morbid allergic diseases. 

Please click here for more information.